A novel cognitive disease progression model for clinical trials in autosomal‐dominant Alzheimer's disease
Guoqiao Wang(Washington University in St. Louis), Randall J. Bateman(Washington University in St. Louis), Paul Delmar(Roche (Switzerland)), Jason Hassenstab(Washington University in St. Louis), Eric McDade(University of Pittsburgh), Melanie Quintana(Berry & Associates (United States)), Matteo Vestrucci(Roche (Switzerland)), Gopalan Sethuraman(Eli Lilly (United States)), Scott Berry(Queen's University), Chengjie Xiong(Guangzhou Institutes of Biomedicine and Health)
Cited by 65
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k